Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:59 PM
Ignite Modification Date:
2025-12-24 @ 7:59 PM
NCT ID:
NCT05101304
Eligibility Criteria:
INCLUSION CRITERIA
1. Patients must meet all of the following inclusion criteria to be included in the study:
* Major patient
* Protected adult patient (guardianship or curatorship)
2. Prospective Cohort:
Patients referred or who have been referred to the participating centre for suspected amyloidosis.
Patient who signed the patient information "Prospective Cohort" note
3. Retro-prospective Cohort:
Patient already followed in the center with a confirmed diagnosis of amyloidosis Patient who signed the "retro-prospective cohort" patient information note
4. Retrospective cohort:
Deceased patients followed in the center with a confirmed diagnosis of amyloidosis
Study participants will not be compensated for their participation
EXCLUSION CRITERIA The patient has expressed his/her refusal to participate Participation in another study, even an interventional one, is not a criterion for non-inclusion.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT05101304
Study Brief:
Protocol Section:
NCT05101304